Fidelity Investments
NPCE icon

Fidelity Investments’s Neuropace NPCE Stock Holding History

Fidelity Investments’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$207K Sell
15,074
-539,697
-97% -$8M ﹤0.01% 3680
2026
Q2 		$8.82M Buy
554,771
+1,242
+0.2% +$20K ﹤0.01% 2186
2026
Q1 		$7.28M Sell
553,529
-71,418
-11% -$1.07M ﹤0.01% 2167
2025
Q4 		$9.6M Buy
624,947
+625
+0.1% +$8.36K ﹤0.01% 2045
2025
Q3 		$6.44M Sell
624,322
-1,124
-0.2% -$10.6K ﹤0.01% 2153
2025
Q2 		$6.97M Buy
625,446
+375,541
+150% +$4.7M ﹤0.01% 2058
2025
Q1 		$3.07M Buy
249,905
+234
+0.1% +$2.93K ﹤0.01% 2318
2024
Q4 		$2.79M Buy
249,671
+261
+0.1% +$2.27K ﹤0.01% 2340
2024
Q3 		$1.74M Buy
249,410
+16
+0% +$117 ﹤0.01% 2437
2024
Q2 		$1.89M Sell
249,394
-53,409
-18% -$539K ﹤0.01% 2363
2024
Q1 		$4M Sell
302,803
-165,278
-35% -$2.36M ﹤0.01% 2135
2023
Q4 		$4.83M Sell
468,081
-238,164
-34% -$1.9M ﹤0.01% 2076
2023
Q3 		$6.87M Sell
706,245
-517,418
-42% -$3.03M ﹤0.01% 1944
2023
Q2 		$5.49M Sell
1,223,663
-269,268
-18% -$1.22M ﹤0.01% 2039
2023
Q1 		$6.93M Buy
1,492,931
+43,005
+3% +$165K ﹤0.01% 2001
2022
Q4 		$2.16M Hold
1,449,926
– – ﹤0.01% 2355
2022
Q3 		$5.44M Buy
1,449,926
+30,975
+2% +$149K ﹤0.01% 2141
2022
Q2 		$7.02M Buy
1,418,951
+11,645
+0.8% +$76.9K ﹤0.01% 2120
2022
Q1 		$11.6M Buy
1,407,306
+341,269
+32% +$2.94M ﹤0.01% 2053
2021
Q4 		$10.7M Buy
1,066,037
+652
+0.1% +$8.47K ﹤0.01% 2090
2021
Q3 		$16.9M Buy
1,065,385
+5,326
+0.5% +$112K ﹤0.01% 1918
2021
Q2 		$25.2M Buy
+1,060,059
New +$24.6M ﹤0.01% 1740

Other funds holding NPCE

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Legato Capital Management
Legato Capital Management San Francisco, California $1.11B AUM 60.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

Fidelity Investments's NPCE Position: Q3 2026 in Review

Fidelity Investments reduced its Neuropace (NPCE) stake by 97% in Q3 2026, selling an estimated $8M and leaving 15,074 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #3680.

Fidelity Investments first reported a position in NPCE in Q2 2021 and has held it in 22 quarters since. The position peaked at $25.2M in Q2 2021. 39 funds tracked by Wall St. Rank hold NPCE as of Q3 2026.

  • Fidelity Investments held 15,074 shares of Neuropace worth $207K as of Q3 2026.
  • Fidelity Investments sold 539,697 Neuropace shares in Q3 2026, an estimated $8M.
  • Neuropace made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #3680 holding.
  • Fidelity Investments first reported a position in Neuropace in Q2 2021 and has held it in 22 quarters since.
  • Fidelity Investments's Neuropace position peaked at $25.2M in Q2 2021.
  • 39 funds tracked by Wall St. Rank held Neuropace as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.